1. Longer patents for increased generic competition: the Waxman Hatch Act after one decade;Grabowski;Pharmacoeconomics,1996
2. Brand Loyalty, Generic Entry, and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Hatch–Waxman Legislation NBER Working Paper No. 16431;Berndt,2010
3. Generic substitution issues: brand–generic substitution, generic–generic substitution, and generic substitution of narrow therapeutic index (NTI)/critical dose drugs;Paveliu;Maedica,2011
4. Drug shortages: a complex health care crisis;Fox;Mayo Clin. Proc.,2014
5. Generic and branded levothyroxine preparations are not bioequivalent in children with congenital hypothyroidism;Carswell;Clin. Thyroidol.,2012